EU regulator to review potential link between Ozempic and eye condition
Investing.com -- The European Medicines Agency (EMA), the drug regulator for the European Union, announced on Wednesday that it will review a potential connection between Novo Nordisk (NYSE: ...
Tesla remains a narrative king within the market: Barclays
Investing.com -- The extraordinary rally in Tesla (NASDAQ: TSLA ) shares since the US election underscores its status as the “narrative king” of the market, according to Bar...
UK seeks alternative jobs data amid ONS survey flaws
Investing.com -- On Wednesday, the UK government acknowledged a crisis in obtaining reliable jobs data, which has become a significant issue for economic policy-making. The Office for National St...
